Cognitive dysfunction, including mild cognitive impairment and dementia, is increasingly
recognised as an important comorbidity and complication of diabetes that affects an …

Abstract Purpose of Review The aims of this review are to summarize recent data on
mortality and cardiovascular disease (CVD) in type 1 and type 2 diabetes and to determine …

Diabetes mellitus is a leading cause of mortality and reduced life expectancy. We aim to
estimate the burden of diabetes by type, year, regions, and socioeconomic status in 195 …

Since the American Diabetes Association (ADA) published the Position Statement “Care of
Children and Adolescents With Type 1 Diabetes”(1) in 2005, innovations have transformed …

Aims Type 1 diabetes has been associated with a significant reduction in life expectancy.
Major advances in treatment of type 1 diabetes have been associated with improved …

OBJECTIVE The degree to which mortality and cardiovascular disease (CVD) incidence
remains elevated in young US adults with type 1 diabetes (T1DM) is unclear. We determined …

Cardiovascular disease remains the leading cause of mortality in patients with type 1
diabetes. Although cardiovascular disease complications are rare until adulthood, pathology …

Background The incidence and temporal trends of moderate and severe albuminuria during
recent decades are poorly described in type 1 diabetes. We aimed to assess diabetes …

Type 1 diabetes (T1D) presents a persistent medical challenge, demanding innovative
strategies for sustained glycemic control and enhanced patient well-being. Beta cells are …

Introduction The incidence of both type 1 diabetes (T1D) and type 2 diabetes (T2D) is
increasing. Life expectancy is improving in T1D, resulting in a growing population of elderly …